COST-EFFECTIVENESS OF A NURSE FACILITATED SELF-MANAGEMENT PROGRAMME FOR HEART FAILURE
Author(s)
Mejia A1, Richardson G2, Cockayne S2, Pattenden J2, Lewin R21Universidad de Antioquia, Medellín, Antioquia, Colombia, 2University of York, York, United Kingdom
Presentation Documents
OBJECTIVES: To assess the cost-effectiveness of a nurse facilitated, cognitive behavioural self-management programme for patients with heart failure compared with usual care including the un-facilitated access to the same manual, from the perspective of the NHS METHODS: Data were obtained from a pragmatic, multi-centre, randomised controlled ‘open’ trial conducted in seven centres in the UK between 2006 and 2008. Effectiveness was estimated as Quality-Adjusted Life Years. Resource use was measured prospectively on all patients using information provided by patients in postal questionnaires, case-note review, electronic record review and interviews with patients. Unit costs were obtained from the literature and applied to the relevant resource use to estimate total costs. Multiple imputation was used to handle missing data. RESULTS: There were no substantial differences in the utility scores between treatment groups in all follow-up assessments, in the use of medication or outpatient visits and both groups report a similar frequency of contact with health care professionals. After controlling for baseline utility and using imputed dataset, treatment was associated with a reduction in QALY of 0.004 and a reduction in costs of £116.2, generating an incremental cost-effectiveness ratio of £29,036 for usual care. The probability that the intervention is cost-effective for thresholds between £20,000 and £30,000 is around 60%. CONCLUSIONS: There is little evidence that the addition of the intervention had any effect on costs or outcomes. The uncertainty around both estimates of cost and effectiveness mean that it is not reasonable to make recommendations based on cost-effectiveness alone.
Conference/Value in Health Info
2012-11, ISPOR Europe 2012, Berlin, Germany
Value in Health, Vol. 15, No. 7 (November 2012)
Code
CV1
Topic
Economic Evaluation
Topic Subcategory
Cost-comparison, Effectiveness, Utility, Benefit Analysis
Disease
Cardiovascular Disorders, Respiratory-Related Disorders